-Accord Healthcare recibe la aprobación para Hetronifly® (Serplulimab) de la Agencia Reguladora de Medicamentos y Atención Médica (MHRA) para el tratamiento de primera línea del cáncer de pulmón de células pequeñas en estadio avanzado (ES-SCLC) Intas y su filial Accord Healthcare lideran...
Hence then, the article about accord healthcare recibe la aprobacion para hetronifly de la mhra para el tratamiento de es sclc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Accord Healthcare recibe la aprobación para Hetronifly® de la MHRA para el tratamiento de ES-SCLC )
Also on site :
- Moltbook, a social network where AI agents hang together, may be ‘the most interesting place on the internet right now’
- World Pickleball League 2026: Mumbai Picklepower go down to Bengaluru Jawana despite Brandon Lane's heroics
- INVESTOR DEADLINE: SLM Corporation a/k/a Sallie Mae (SLM) Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces